Adherence and treatment discontinuation of oral semaglutide and once‐weekly semaglutide injection at 12 month follow‐up: Japanese real‐world data

Adherence and treatment discontinuation of oral semaglutide and once‐weekly semaglutide injection at 12 month follow‐up: Japanese real‐world data

Abstract Adherence and treatment continuation rates of the glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) semaglutide for both oral (O‐SEMA) and subcutaneous injection (SEMA‐SC) remain unknown in real‐world clinical practice. This retrospective observational study compared the 12 month adherence...

Full description

Bibliographic Details
Main Authors: Takeshi Horii, Chikako Masudo, Yui Takayanagi, Yoichi Oikawa, Akira Shimada, Kiyoshi Mihara
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Journal of Diabetes Investigation
Subjects:
Injection
Oral
Semaglutide
Online Access:https://doi.org/10.1111/jdi.14265

Internet

https://doi.org/10.1111/jdi.14265

Similar Items